The pharmaceutical industry stands at a critical juncture as the European Medicines Agency (EMA) advances its implementation of ISO Identification of Medicinal Products (IDMP) standards through the ...

Following global reports of serious adverse events in older people, the government’s independent expert advisory body, the UK ...

Spread mainly by fruit bats, Nipah virus is fatal in up to 85% of cases. Symptoms include fever, headaches, pain, vomiting ...

Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines, confirming a ...

Amvuttra is the first and only RNA interference (RNAi) therapeutic approved by the EC for both the cardiomyopathy and the ...

Couple campaigning for the Government to sanction pay for a new drug called givinostat, which slows down muscle-wasting ...

Amtagvi ® and its accompanying design marks, Proleukin ®, Iovance ®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other ...

Bulgaria wants areas of national competence respected, especially for drug reimbursement decisions to remain within the member states.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the European Commission (EC) to treat adults with ...

Results from the study’s open-label period, presented at this year’s European Renal Association Congress, showed that ...

Archie Ennis suffers from Duchenne muscular dystrophy and is in desperate need of medication to help his condition ...